Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $300.00 (Oppenheimer)
- Lowest: $157.00 (HSBC)
- Average: $230.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$230.14 (+7.1%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$230.14 (+7.1%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Wolfe Research | Alexandria Hammond | Upgrade | Outperform (Peerperform) |
300.00 (N/A) |
208.87 (214.95) |
2.91% | Details |
| 7/13/2026 | Truist Securities | Danielle Brill | Upgrade | Buy (Hold) |
235.00 (N/A) |
199.15 (214.95) |
7.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
